Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Eros Capital Partners AB | 600,000 | net | 20 Aug 2025 | tx 1+600,000 |
| Emplicure | 454,728 | net | 12 May 2022 | tx 3+454,728 |
| Promore Pharma | 64,116 | net | 01 Dec 2021 | tx 4+64,116 |
| Promore Pharma | 18,666 | net | 31 Mar 2021 | tx 2+18,666 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Aug 2025 | PURCHASE | Eros Capital Partners AB | 600,000 | 0.09 SEK | first after silence |
| 12 May 2022 | OTHER | Emplicure | 151,576 | 2.09 SEK | |
| 12 May 2022 | OTHER | Emplicure | 151,576 | 2.09 SEK | deriv |
| 11 May 2022 | PURCHASE | Emplicure | 151,576 | 0.03 SEK | deriv |
| 01 Dec 2021 | PURCHASE | Promore Pharma | 39,800 | 1.58 SEK | |
| 16 Jun 2021 | GRANT_AWARD | Promore Pharma | 17,272 | 2.00 SEK | |
| 31 Mar 2021 | PURCHASE | Promore Pharma | 8,666 | 2.89 SEK | |
| 26 Nov 2020 | PURCHASE | Promore Pharma | 4,044 | 3.60 SEK | |
| 26 Nov 2020 | PURCHASE | Promore Pharma | 3,000 | 3.66 SEK | |
| 25 Nov 2020 | PURCHASE | Promore Pharma | 10,000 | 3.36 SEK |
1 purchase reported after at least 12 months of silence — most recent on 20 Aug 2025.